Microbot Medical Lands First Midwest Health System Adoption of LIBERTY System
MBOT•One of Michigan’s largest health networks becomes the first in the Midwest to adopt Microbot Medical’s LIBERTY Endovascular Robotic System. This follows its North Carolina rollout and targets a U.S. peripheral endovascular market performing roughly 2.5 million procedures annually.
1. First Midwest Health System Adoption
Microbot Medical announced that one of Michigan’s largest healthcare networks is the first in the Midwest to implement the LIBERTY Endovascular Robotic System, marking the company’s initial entry into the state and extending its U.S. market footprint beyond its North Carolina launch.
2. Strategic U.S. Expansion
This installation reflects the company’s full market release strategy, reinforcing growing demand for robotic solutions in peripheral endovascular procedures and demonstrating successful penetration into multiple strategic U.S. regions.
3. Market Opportunity and Device Advantages
The U.S. peripheral endovascular market accounts for approximately 2.5 million procedures annually, presenting a significant commercial opportunity. LIBERTY’s single-use, remotely operated design aims to improve procedural precision while reducing radiation exposure and operator fatigue.
